Calmare Therapeutics Financials

Calmare Therapeutics Stock Summary

Calmare Therapeutics competes with BioNTech, Teleflex Incorporated, Modine Manufacturing, U Power, and Merit Medical. Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut. Calmare Therapeutics operates under Medical Devices classification in the United States and is traded on NYSEMKT Exchange. It employs 7 people.

Calmare Therapeutics Key Financial Ratios

Calmare Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Calmare Therapeutics's current stock value. Our valuation model uses many indicators to compare Calmare Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Calmare Therapeutics competition to find correlations between indicators driving Calmare Therapeutics's intrinsic value. More Info.Calmare Therapeutics is rated third in return on asset category among its peers. It is number one stock in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Calmare Therapeutics' earnings, one of the primary drivers of an investment's value.

Calmare Therapeutics Market Pulse

Along with financial statement analysis, the daily predictive indicators of Calmare Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Calmare Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Calmare Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Calmare Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Calmare Therapeutics's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

If you are still planning to invest in Calmare Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calmare Therapeutics' history and understand the potential risks before investing.